SPOP and neoplasm: Recently, a study suggested that miRNA-17-5p can target SPOP and that upregulation of miRNA-17-5p can downregulate SPOP to promote proliferation and inhibit anti-tumor immunity in CRC through the overexpression of PD-L1 [130].